People with Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Exhibit Similarly Impaired Vascular

Marie Mclaughlin1, Nilihan E M Sanal-Hayes2, Lawrence D Hayes3

  • 1Sport and Physical Activity Research Institute, School of Health and Life Sciences, University of the West of Scotland, Glasgow, United Kingdom; School of Sport, Exercise & Rehabilitation Sciences, Faculty of Health Sciences, University of Hull, United Kingdom.

PubMed

Insights

Individuals with long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) show similar impaired endothelial function. This suggests vascular involvement and increased cardiovascular risk in both post-viral conditions.

Area of Science:

  • Cardiovascular Research
  • Post-Viral Syndromes
  • Endothelial Function

Background:

  • Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) are complex post-viral conditions with overlapping symptoms.
  • Understanding the underlying pathophysiology, particularly vascular involvement, is crucial for effective clinical management and improving long-term health outcomes.

Purpose of the Study:

  • To compare flow-mediated dilation (FMD) in individuals with long COVID, ME/CFS, and healthy controls.
  • To assess potential vascular dysfunction and its implications for these patient groups.

Main Methods:

  • A case-case-control study involving 51 participants (17 long COVID, 17 ME/CFS, 17 healthy controls).
  • Flow-mediated dilation (FMD) measurements of brachial artery diameter were obtained and analyzed using 1-way ANOVA.

Main Results:

  • Both long COVID and ME/CFS groups exhibited significantly impaired endothelial function compared to healthy controls (FMD values: 6.99% and 6.60% vs 11.30%, P < .05).
  • No significant difference in FMD was observed between long COVID and ME/CFS groups (P = .949).
  • ME/CFS patients had a significantly longer illness duration (16 years) than long COVID patients (1.36 years) (P < .0001).

Conclusions:

  • Long COVID and ME/CFS share similarly impaired endothelial function, suggesting common vascular mechanisms in post-viral syndromes.
  • Reduced FMD indicates potential increased cardiovascular risk, necessitating monitoring and targeted interventions for endothelial health.
Abstract

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
7
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
12
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
9
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
12